Affimed N.V. buy Laidlaw
Start price
13.06.24
/
50%
€0.55
Target price
13.06.25
€23.22
Performance (%)
-
End price
14.06.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Affimed N.V. | - | - | - |
| iShares Core DAX® | -0.975% | -4.716% | 4.787% |
| iShares Nasdaq 100 | 1.163% | 1.881% | 20.234% |
| iShares Nikkei 225® | -1.593% | -5.385% | 31.353% |
| iShares S&P 500 | -0.278% | 0.327% | 13.911% |
Comments by Laidlaw for this prediction
In the thread Affimed N.V. diskutieren
Affimed (NASDAQ: AFMD) had its price target raised by analysts at Laidlaw from $15.00 to $25.00. They now have a "buy" rating on the stock.
Ratings data for AFMD provided by MarketBeat
In the thread Trading Affimed N.V.
Die von Laidlaw gewählte maximale Laufzeit wurde überschritten